Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 21;17(7):sfae189.
doi: 10.1093/ckj/sfae189. eCollection 2024 Jul.

Unexpected seronegative response in relapsed PLA2R-associated membranous nephropathy

Wing Yin Leung  1 , Henry H L Wu  2 , Beena Nair  3 , Alexander Woywodt  1   4 , Arvind Ponnusamy  1   4
Affiliations

Unexpected seronegative response in relapsed PLA2R-associated membranous nephropathy

Wing Yin Leung et al. Clin Kidney J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

A.W. is an editor of CKJ. The other authors have no disclosures or conflicts of interest to declare for this manuscript. There is no external funding received for this manuscript.

Figures

Figure 1:
Figure 1:
Kidney biopsy findings during the second relapse episode of PLA2R-associated membranous nephropathy. (A) Electron microscopy of kidney biopsy tissue displaying subepithelial electron-dense deposits along glomerular basement membrane; (B) Positive immunostaining on kidney biopsy suggestive of PLA2R-positive membranous glomerulonephritis (at ×40 magnification).
See this image and copyright information in PMC

References

    1. Beck LH Jr, Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009;361:11–21. 10.1056/NEJMoa0810457 - DOI - PMC - PubMed
    1. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group . KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 2021;100:S1–276. 10.1016/j.kint.2021.05.021 - DOI - PubMed
    1. Ruggenenti P, Debiec H, Ruggiero B et al. Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy. J Am Soc Nephrol 2015;26:2545–58. 10.1681/ASN.2014070640 - DOI - PMC - PubMed
    1. Burbelo PD, Joshi M, Chaturvedi A et al. Detection of PLA2R autoantibodies before the diagnosis of membranous nephropathy. J Am Soc Nephrol 2020;31:208–17. 10.1681/ASN.2019050538 - DOI - PMC - PubMed
    1. Pescovitz MD, Torgerson TR, Ochs HD et al. Effect of rituximab on human in vivo antibody immune responses. J Allergy Clin Immunol 2011;128:1295–302. 10.1016/j.jaci.2011.08.008 - DOI - PMC - PubMed

LinkOut - more resources